← Back to directory
Vesa Kataja
Researcher Next ID · RN-007387
Researcher · Biochemistry, Genetics and Molecular Biology
South Eastern Finland University of Applied Sciences
Mikkeli, Finland
Not currently recruitingFunding unknown
- Works count
- 335
- Citation count
- 27,508
- H-index
- 77
- i10-index
- 203
Research interests
Biochemistry, Genetics and Molecular Biology
Medicine
BRCA gene mutations in cancer
Breast Cancer Treatment Studies
Prostate Cancer Treatment and Research
HER2/EGFR in Cancer Research
Estrogen and related hormone effects
Publications
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu112
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa053028
Current projects
No projects listed.